Xeltis Executive to Discuss U.S. Market Access Strategy at LSX World Congress

According to a recent LinkedIn post from Xeltis, Chief Medical Officer Paulo Neves is scheduled to speak at the LSX World Congress in Lisbon on a MedTech panel focused on the U.S. market. The session is described as addressing how European MedTech companies can navigate policy, investor sentiment, reimbursement, distribution, and commercial execution in the U.S.

The post suggests Xeltis is positioning itself within a network of MedTech innovators and investors that are active in cross‑border market access. For investors, this visibility at a strategic industry forum may indicate ongoing efforts to refine U.S. go‑to‑market strategies, potentially supporting future commercialization prospects and partnership opportunities in a key growth market.